ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0869

Comparison of Two Frailty Definitions in Women with Systemic Lupus Erythematosus

Sarah Lieber1, Musarrat Nahid2, Alexandra Legge3, Mangala Rajan2, Robyn Lipschultz1, Myriam Lin1 and Lisa Mandl1, 1Hospital for Special Surgery, New York, NY, 2Weill Cornell Medicine, New York, NY, 3Dalhousie University, Halifax, NS, Canada

Meeting: ACR Convergence 2021

Keywords: frail, Patient reported outcomes, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 7, 2021

Title: SLE – Diagnosis, Manifestations, & Outcomes Poster II: Manifestations (0855–0896)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Frailty is a novel risk factor for adverse health outcomes in systemic lupus erythematosus (SLE). Multiple definitions of frailty, including the Fried definition (FD), a disease-agnostic phenotypic definition, and the Systemic Lupus International Collaborating Clinics Frailty Index (SLICC-FI), a SLE-specific cumulative deficits definition, have been used to measure frailty in SLE [1,2]. However, the relationship between these two definitions of frailty has not been evaluated. We aimed to determine the prevalence of frailty according to the FD and the SLICC-FI in a single center cohort of adult women with SLE, as well as the cross-sectional association of each frailty definition with self-reported disability.

Methods: Women 18-70 years of age with SLE validated according to the 1997 Update of the 1982 American College of Rheumatology Revised Classification Criteria were enrolled. Frailty status according to the FD and the SLICC-FI was measured at a single study visit. Agreement between frailty metrics was determined using a kappa statistic. Sociodemographic features, physician-reported disease activity and damage, Patient Reported Outcome Measurement Information System (PROMIS) computerized adaptive tests, and Valued Life Activities (VLA) self-report disability were assessed. Differences between frail and non-frail participants were evaluated using Fisher’s exact, Chi-squared, or Wilcoxon rank sum tests. The cross-sectional association of frailty according to each metric and VLA disability was assessed using logistic regression.

Results: Data from 67 participants were available for analysis. 12 (17.9%) and 18 (26.7%) of women were classified as frail according to the FD and the SLICC-FI, respectively. There was moderate agreement between frailty metrics (kappa = 0.41, p< 0.01). Compared to non-frail women, frail women had lesser educational attainment (FD: p=0.05; SLICC-FI: p=0.03) and greater disease damage (FD and SLICC-FI: p< 0.01) (Table 1). Frail women according to the FD were also older (p=0.05) with greater comorbidity burden (p< 0.01) and more likely to have smoked over their lifetime (p=0.02) than non-frail women (Table 1). Frail women according to the SLICC-FI had greater disease damage (p< 0.01) than non-frail women (Table 1). Frail women according to either definition had worse PROMIS scores across multiple domains (p< 0.01) and greater VLA disability (p< 0.01) than non-frail women (Table 2). After adjusting for age, frailty according to either definition was still significantly associated with greater odds of VLA disability (Table 3).

Conclusion: Frailty prevalence was higher according to the SLICC-FI than the FD in this single center cohort of women with SLE. Agreement was moderate and clinical characteristics differed between participants classified as frail according to each metric, suggesting differences in frailty constructs. Further studies are needed to explore discrepancies in frailty metrics to determine which may best predict relevant health-related outcomes in patients with SLE.

References:

1. Bandeen-Roche et al. J Gerontol A Biol Sci Med Sci 2006;61:262-6.
2. Legge et al. J Rheumatol 2020;47:72-81.

Table 1. Characteristics of women with SLE by frailty classification

Table 2. Patient-reported outcome measures among women with SLE by frailty classification

Table 3. Cross-sectional association of frailty with disability in women with SLE


Disclosures: S. Lieber, None; M. Nahid, None; A. Legge, None; M. Rajan, None; R. Lipschultz, None; M. Lin, None; L. Mandl, Regeneron Pharmaceuticals, 5.

To cite this abstract in AMA style:

Lieber S, Nahid M, Legge A, Rajan M, Lipschultz R, Lin M, Mandl L. Comparison of Two Frailty Definitions in Women with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/comparison-of-two-frailty-definitions-in-women-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/comparison-of-two-frailty-definitions-in-women-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology